Fumaric Acid

Fumaric Acid

SCHEMBL5987263

CC(N)CC(C)c1cc(F)cc2ccoc12.O=C(O)/C=C/C(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.34
BLM P54132 1/20 0.34
LMNA P02545 1/20 0.32
PMP22 Q01453 1/20 0.32
GFER P55789 1/20 0.32
P4HB P07237 1/20 0.31
KCNA3 P22001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5987268 1.00 NPSR1 (0.34) NPSR1BLMLMNAPMP22GFER
Fumaric Acid SCHEMBL5988615 0.80 NPSR1 (0.34) NPSR1BLMLMNAPMP22GFER
Fumaric Acid SCHEMBL5988148 0.80 NPSR1 (0.34) NPSR1BLMLMNAPMP22GFER
SCHEMBL5987266 0.80 LMNA (0.32) LMNA
SCHEMBL5986612 0.75 P4HB (0.32) P4HB
Oxalic Acid SCHEMBL5987258 0.75 P4HB (0.32) P4HB
SCHEMBL5986973 0.72 P4HB (0.33) P4HB
Hydrochloric Acid SCHEMBL5985527 0.71 TRPA1 (0.33) P4HB
SCHEMBL5988125 0.70 P4HB (0.33) P4HB
Fumaric Acid SCHEMBL5987201 0.70 BLM (0.42) NPSR1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045545-B1 Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists ELI LILLY AND COMPANY (US) 2006-05-16 US disclosed